What is the share price of Narayana Hrudayalaya Ltd (NH) today?
The share price of NH as on 23rd May 2025 is ₹1724.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Narayana Hrudayalaya Ltd (NH) share?
The past returns of Narayana Hrudayalaya Ltd (NH) share are- Past 1 week: -5.01%
- Past 1 month: -6.47%
- Past 3 months: 23.45%
- Past 6 months: 37.33%
- Past 1 year: 37.39%
- Past 3 years: 172.16%
- Past 5 years: 561.96%
What are the peers or stocks similar to Narayana Hrudayalaya Ltd (NH)?
The peers or stocks similar to Narayana Hrudayalaya Ltd (NH) include:What is the dividend yield % of Narayana Hrudayalaya Ltd (NH) share?
The current dividend yield of Narayana Hrudayalaya Ltd (NH) is 0.23.What is the market cap of Narayana Hrudayalaya Ltd (NH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Narayana Hrudayalaya Ltd (NH) is ₹34988.01 Cr as of 23rd May 2025.What is the 52 week high and low of Narayana Hrudayalaya Ltd (NH) share?
The 52-week high of Narayana Hrudayalaya Ltd (NH) is ₹1871.60 and the 52-week low is ₹1080.What is the PE and PB ratio of Narayana Hrudayalaya Ltd (NH) stock?
The P/E (price-to-earnings) ratio of Narayana Hrudayalaya Ltd (NH) is 44.33. The P/B (price-to-book) ratio is 12.13.Which sector does Narayana Hrudayalaya Ltd (NH) belong to?
Narayana Hrudayalaya Ltd (NH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Narayana Hrudayalaya Ltd (NH) shares?
You can directly buy Narayana Hrudayalaya Ltd (NH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Narayana Hrudayalaya Ltd
NH Share Price
1,724.400.10% (+1.70)
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
NH Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 44.65 | 12.13 | 0.23% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.78 | 6.46 | 0.86% |
NH Analyst Ratings & Forecast
Detailed Forecast 67%
Analysts have suggested that investors can buy this stock
from 12 analysts
Price Upside
Earnings Growth
Rev. Growth
NH Company Profile
Narayana Hrudayalaya Ltd is engaged in operating a network of hospitals in India. The Company has hospitals in southern state of Karnataka and eastern India, as well as in western and central India.
NH Similar Stocks (Peers)
Compare with peersMAXHEALTH
PE Ratio
103.75
1Y Return
42.98%
Buy Reco %
75.00
APOLLOHOSP
PE Ratio
111.28
1Y Return
16.49%
Buy Reco %
86.21
FORTIS
PE Ratio
70.58
1Y Return
54.34%
Buy Reco %
100.00
MEDANTA
PE Ratio
66.09
1Y Return
1.46%
Buy Reco %
71.43
ASTERDM
PE Ratio
5.28
1Y Return
57.03%
Buy Reco %
100.00
NH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
NH Stock Summary · February 2025
The recent earnings call highlighted a cautiously optimistic outlook, driven by the operational launch of a new outpatient facility in the Cayman Islands, which is expected to enhance future revenue streams despite initial cost burdens. In India, new hospitals are showing improved EBITDA, particularly in Gurugram and Dharamshala, while operational efficiencies are being prioritized to manage costs effectively. However, challenges persist in attracting medical tourists and negotiating brownfield expansions, prompting a strategic focus on enhancing local healthcare accessibility. The company is also exploring innovative insurance products tailored for families and senior citizens, aiming to build long-term patient loyalty despite initial losses. Overall, a balanced approach to expansion and investment is being adopted, reflecting a commitment to operational excellence and financial discipline.
Key Points on Nh Stock
NH Stock Growth Drivers
7Operational Success of New Outpatient Facility
The new outpatient facility that commenced operations in December has shown positive initial responses, contributing
Improvement in Financial Performance
There has been a marked improvement in the financial performance of new hospitals, with combined
NH Stock Challenges
4Cost Escalation and Operational Readiness Challenges
The company is facing anticipated cost escalations as it approaches Q1, primarily due to increases
Underperformance in Capital Expenditure
The company has significantly underperformed in its capital expenditure (Capex) plans, having spent only INR
NH Forecasts
NH Forecast
Price
Revenue
Earnings
NH Share Price Forecast
2025
Current
₹1,724.40
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,724.40
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
NH Company Revenue Forecast
2024
Current
₹5.09
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2024
Current
₹5.09
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
NH Stock EPS (Earnings Per Share) Forecast
2024
Current
₹38.62
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹38.62
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
NH
Income
Balance Sheet
Cash Flow
Annual Normal View
NH Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,606.79 | 1,887.72 | 2,301.51 | 2,877.59 | 3,151.57 | 2,610.53 | 3,735.88 | 4,590.22 | 5,093.44 | 5,476.37 | ||||||||||
Raw Materials | 385.63 | 438.88 | 566.63 | 687.10 | 722.36 | 665.45 | 920.72 | 1,012.27 | 1,112.31 | 4,173.19 | ||||||||||
| Power & Fuel Cost | 47.16 | 49.90 | 65.08 | 77.98 | 81.19 | 73.52 | 83.63 | 94.04 | 104.79 | |||||||||||
| Employee Cost | 333.84 | 375.21 | 465.69 | 622.77 | 673.70 | 627.19 | 768.47 | 879.20 | 1,004.30 | |||||||||||
| Selling & Administrative Expenses | 165.17 | 138.91 | 184.55 | 234.88 | 851.54 | 700.68 | 869.01 | 1,073.34 | 1,199.25 | |||||||||||
| Operating & Other expenses | 514.52 | 641.97 | 784.68 | 943.30 | 381.84 | 333.87 | 404.69 | 485.66 | 430.26 | |||||||||||
EBITDA | 160.47 | 242.85 | 234.88 | 311.56 | 440.94 | 209.82 | 689.36 | 1,045.71 | 1,242.53 | 1,303.18 | ||||||||||
| Depreciation/Amortization | 76.12 | 79.92 | 99.95 | 137.36 | 185.80 | 183.53 | 183.48 | 210.04 | 242.14 | 261.54 | ||||||||||
| PBIT | 84.35 | 162.93 | 134.93 | 174.20 | 255.14 | 26.29 | 505.88 | 835.67 | 1,000.39 | 1,041.64 | ||||||||||
| Interest & Other Items | 33.40 | 27.58 | 54.57 | 80.80 | 93.84 | 82.35 | 76.09 | 84.09 | 111.86 | 133.75 | ||||||||||
| PBT | 50.95 | 135.35 | 80.36 | 93.40 | 161.30 | -56.06 | 429.79 | 751.58 | 888.53 | 907.89 | ||||||||||
| Taxes & Other Items | 29.73 | 52.29 | 29.02 | 34.23 | 42.39 | -41.77 | 87.85 | 145.33 | 99.26 | 124.27 | ||||||||||
| Net Income | 21.22 | 83.06 | 51.34 | 59.17 | 118.91 | -14.29 | 341.94 | 606.25 | 789.27 | 783.62 | ||||||||||
| EPS | 1.05 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.34 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | 1.00 | 2.50 | 4.00 | 4.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.35 | 0.17 | 0.00 | 0.06 | 0.08 | 0.10 | 0.10 |
NH Company Updates
FY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFNH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Narayana Hrudayalaya Ltd | 44.33 | 12.13 | 0.23% |
| Max Healthcare Institute Ltd | 103.75 | 13.28 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 111.28 | 13.66 | 0.23% |
| Fortis Healthcare Ltd | 70.58 | 6.39 | 0.14% |
NH Stock Price Comparison
Compare NH with any stock or ETFCompare NH with any stock or ETF
NH
NH Shareholdings
NH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NH Shareholding Pattern
NH Shareholding History
Foreign Institutions
Mutual Funds Invested in NH
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Narayana Hrudayalaya Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2709% | Percentage of the fund’s portfolio invested in the stock 1.91% | Change in the portfolio weight of the stock over the last 3 months 0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/137 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0043% | Percentage of the fund’s portfolio invested in the stock 0.36% | Change in the portfolio weight of the stock over the last 3 months 0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 84/151 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7176% | Percentage of the fund’s portfolio invested in the stock 3.04% | Change in the portfolio weight of the stock over the last 3 months 0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 12/40 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing NH stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Narayana Hrudayalaya Ltd
NH Events
NH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NH Upcoming Dividends
No upcoming dividends are available
NH Past Dividends
Cash Dividend
Ex DateEx DateAug 2, 2024
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 2, 2024
Cash Dividend
Ex DateEx DateJul 7, 2023
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Jul 7, 2023
Cash Dividend
Ex DateEx DateAug 22, 2022
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 22, 2022
Cash Dividend
Ex DateEx DateMar 11, 2020
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Mar 11, 2020
Cash Dividend
Ex DateEx DateAug 1, 2019
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 1, 2019
NH Stock News & Opinions
Articles & Videos
Corporate
Narayana Hrudayalaya to declare Quarterly Results
Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
6 days agoCapital Market - Live
Spotlight
Narayana Hrudayalaya inks O&M pact with Kammavari Sangham for 110-bed hospital
Kammavari Sangham will set-up hospital infrastructure with capacity of 110 beds in the Bengaluru South region. The project is expected to commence operations in the FY 2026-27. Under the terms of the agreement, Kammavari Sangham shall provide hospital facility to Narayana Hrudayalaya in the Bengaluru South region on a long-term basis. The company would run and operate the said hospital as per the terms of the agreement. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company's consolidated net profit increased 2.6% to Rs 192.94 crore in Q3 FY25 as compared with Rs 188.02 crore in Q3 FY24. Net sales jumped 13.5% YoY to Rs 1366.68 crore during the quarter ended 31st December 2024. The scrip had gained 0.76% to end at Rs 1677.90 on the BSE on Friday. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Narayana Hrudayalaya enters into O&M agreement with Kammavari Sangham
Narayana Hrudayalaya has entered into an operation and management agreement with M/s. Kammavari Sangham, a registered Society under the Karnataka Societies Registration Act 1960 to govern the operation, maintenance, overall management of the hospital to be built by M/s. Kammavari Sangham and to provide healthcare services. The purpose of the agreement is to set-up hospital infrastructure to be run and operated by Narayana Hrudayalaya with capacity of 110 beds in the Bengaluru South region. The Project is expected to commence operations in the FY 2026-27.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Narayana Hrudayalaya rises after arm inks JV pact for chemotherapy services in India
The joint venture agreement aims to establish and operate a network of healthcare centers in India, specifically for the treatment of cancer patients, with a focus on chemotherapy treatment through the JV company. 2070 Health Inc. and W Health Ventures GP LLC are both incorporated under the laws of Delaware, USA while Everhope Oncology Private, is the joint venture company. The equity subscription by parties will take place in three tranches over a period of time, HCCI will hold 50%, 2070 Health will hold 20% and W health Ventures GP LLC will hold 30% of the shareholding. The company said that the total investment over a period of next 1 to 2 years is expected to be $10 million. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company's consolidated net profit increased 2.6% to Rs 192.94 crore in Q3 FY25 as compared with Rs 188.02 crore in Q3 FY24. Net sales jumped 13.5% YoY to Rs 1366.68 crore during the quarter ended 31st December 2024.Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Volumes spurt at Narayana Hrudayalaya Ltd counter
Gland Pharma Ltd, CreditAccess Grameen Ltd, Tata Investment Corporation Ltd, Adani Power Ltd are among the other stocks to see a surge in volumes on NSE today, 25 February 2025.Narayana Hrudayalaya Ltd notched up volume of 43.73 lakh shares by 14:14 IST on NSE, a 13.11 fold spurt over two-week average daily volume of 3.33 lakh shares. The stock rose 6.01% to Rs.1,477.00. Volumes stood at 2.8 lakh shares in the last session.Gland Pharma Ltd registered volume of 12.91 lakh shares by 14:14 IST on NSE, a 8.49 fold spurt over two-week average daily volume of 1.52 lakh shares. The stock rose 4.68% to Rs.1,596.80. Volumes stood at 3.48 lakh shares in the last session.CreditAccess Grameen Ltd recorded volume of 75 lakh shares by 14:14 IST on NSE, a 5.71 times surge over two-week average daily volume of 13.14 lakh shares. The stock gained 2.66% to Rs.876.20. Volumes stood at 10.38 lakh shares in the last session.Tata Investment Corporation Ltd recorded volume of 12.46 lakh shares by 14:14 IST on NSE, a 5.65 times surge over two-week average daily volume of 2.21 lakh shares. The stock gained 6.41% to Rs.6,123.95. Volumes stood at 72078 shares in the last session.Adani Power Ltd witnessed volume of 184.56 lakh shares by 14:14 IST on NSE, a 5.41 times surge over two-week average daily volume of 34.15 lakh shares. The stock increased 7.82% to Rs.506.85. Volumes stood at 19.26 lakh shares in the last session.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Narayana Hrudayalaya consolidated net profit rises 2.62% in the December 2024 quarter
Net profit of Narayana Hrudayalaya rose 2.62% to Rs 192.94 crore in the quarter ended December 2024 as against Rs 188.02 crore during the previous quarter ended December 2023. Sales rose 13.55% to Rs 1366.68 crore in the quarter ended December 2024 as against Rs 1203.64 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1366.681203.64 14 OPM %22.4623.17 - PBDT288.79271.77 6 PBT218.82208.59 5 NP192.94188.02 3 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Narayana Hrudayalaya to discuss results
Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Narayana Hrudayalaya announces infusion of USD 1.5 million in Cayman Integrated Healthcare
Narayana Hrudayalaya announced that Health City Cayman Islands (HCCI), a wholly owned overseas subsidiary of the Company has infused an amount of USD 1.5 Million in Cayman Integrated Healthcare (CIHL), a wholly-owned overseas subsidiary of HCCI and a step-down subsidiary of the Company by way of subscription to its equity shares equivalent to USD 1.5 Million, i.e., 150,000 ordinary shares in the capital of the Company, each as fully paid, with the value of each ordinary shares being set at US$ 10.00, which is comprised US$0.01 of par value and US$ 9.99 of share premium. The above-mentioned shares have been allotted by CIHL to HCCI on 06 December 2024 (Friday). With this investment, the total investment of HCCI in CIHL stands at USD 5,550,000.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Narayana Hrudayalaya consolidated net profit declines 12.34% in the September 2024 quarter
Net profit of Narayana Hrudayalaya declined 12.34% to Rs 198.63 crore in the quarter ended September 2024 as against Rs 226.58 crore during the previous quarter ended September 2023. Sales rose 7.26% to Rs 1400.01 crore in the quarter ended September 2024 as against Rs 1305.25 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1400.011305.25 7 OPM %22.0323.61 - PBDT296.90303.66 -2 PBT231.77248.39 -7 NP198.63226.58 -12 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Narayana Hrudayalaya to discuss results
Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 31 October 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.1%, vs industry avg of 10.01%
Over the last 5 years, market share increased from 7.84% to 8.01%
Over the last 5 years, net income has grown at a yearly rate of 67.89%, vs industry avg of 42.91%